Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize ...

Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can m ...

Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...

Patients using GLP-1 drugs had no difference in the odds of postoperative aspiration pneumonia versus non-users. Preoperative ...

GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study sugges ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

This cohort study found no significant association between the preoperative use of glucagon-like peptide-1 receptor agonists (GLP-1 ...

Findings support guidance recommending that a GLP-1 agent hiatus is not necessary before surgery. Preoperative use of GLP-1 receptor agonists was not significantly associated with short-term ...

Highlights of the findings include: Stopping Ozempic three to five days prior to surgery was identified as an independent risk factor for delayed emergence from anesthesia. In contrast ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.